Literature DB >> 28302313

Influenza.

Catharine Paules1, Kanta Subbarao2.   

Abstract

Influenza is an acute respiratory illness, caused by influenza A, B, and C viruses, that occurs in local outbreaks or seasonal epidemics. Clinical illness follows a short incubation period and presentation ranges from asymptomatic to fulminant, depending on the characteristics of both the virus and the individual host. Influenza A viruses can also cause sporadic infections or spread worldwide in a pandemic when novel strains emerge in the human population from an animal host. New approaches to influenza prevention and treatment for management of both seasonal influenza epidemics and pandemics are desirable. In this Seminar, we discuss the clinical presentation, transmission, diagnosis, management, and prevention of seasonal influenza infection. We also review the animal-human interface of influenza, with a focus on current pandemic threats.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28302313     DOI: 10.1016/S0140-6736(17)30129-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  194 in total

1.  [Influenza: special aspects in old age].

Authors:  A Kwetkat; A Leischker; H J Heppner
Journal:  Z Gerontol Geriatr       Date:  2018-06-27       Impact factor: 1.281

2.  Effectiveness of seasonal inactivated influenza vaccination in Japanese schoolchildren: an epidemiologic study at the community level.

Authors:  Yasutaka Kuniyoshi; Taku Obara; Mami Ishikuro; Hiroko Matsubara; Masato Nagai; Keiko Murakami; Aoi Noda; Masahiro Kikuya; Shigeo Kure; Shinichi Kuriyama
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

3.  Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza.

Authors:  Michelle M Thomsen; Sofie E Jørgensen; Hans Henrik Gad; Merete Storgaard; Jakob Gjedsted; Mette Christiansen; Rune Hartmann; Trine H Mogensen
Journal:  Med Microbiol Immunol       Date:  2019-06-06       Impact factor: 3.402

4.  Influenza Vaccines: Good, but We Can Do Better.

Authors:  Catharine I Paules; Anthony S Fauci
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

5.  Influenza-associated intrapelvic myositis in an elderly person presenting with gait disturbance.

Authors:  Hiroaki Iwasaki
Journal:  BMJ Case Rep       Date:  2019-05-08

6.  Influenza vaccination and the 'diversity paradox'.

Authors:  Craig P Thompson; Uri Obolski
Journal:  Hum Vaccin Immunother       Date:  2018-09-21       Impact factor: 3.452

7.  Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Authors:  David T Gilbertson; Kenneth J Rothman; Glenn M Chertow; Brian D Bradbury; M Alan Brookhart; Jiannong Liu; Wolfgang C Winkelmayer; Til Stürmer; Keri L Monda; Charles A Herzog; Akhtar Ashfaq; Allan J Collins; James B Wetmore
Journal:  J Am Soc Nephrol       Date:  2019-01-24       Impact factor: 10.121

8.  Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy volunteers.

Authors:  Sofie Deleu; Thomas N Kakuda; Kurt Spittaels; Jurgen J Vercauteren; Vera Hillewaert; Amy Lwin; Lorant Leopold; Richard M W Hoetelmans
Journal:  Br J Clin Pharmacol       Date:  2018-09-14       Impact factor: 4.335

9.  Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.

Authors:  Maya Sangesland; Larance Ronsard; Samuel W Kazer; Julia Bals; Seyhan Boyoglu-Barnum; Ashraf S Yousif; Ralston Barnes; Jared Feldman; Maricel Quirindongo-Crespo; Patrick M McTamney; Daniel Rohrer; Nils Lonberg; Bryce Chackerian; Barney S Graham; Masaru Kanekiyo; Alex K Shalek; Daniel Lingwood
Journal:  Immunity       Date:  2019-09-25       Impact factor: 31.745

10.  Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).

Authors:  Taylor Heald-Sargent; William J Muller; Xiaotian Zheng; Jason Rippe; Ami B Patel; Larry K Kociolek
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.